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Abstract
Background and Aims: In Niger, acute respiratory infections (ARIs) are the second
most common cause of death in children aged younger than 5 years. However, the
etiology of ARI is poorly understood in the country. This study aims to describe viral
and bacterial infections among children aged younger than 5 years hospitalized with
febrile ARI at two hospitals in Niamey, Niger's capital city, and the reported clinical
procedures.
Methods: We conducted a prospective study among children aged younger than
5 years hospitalized with febrile ARI at two national hospitals in Niamey between
January and December 2015. Clinical presentation and procedures during admission
were documented using a standardized case investigation form. Nasopharyngeal
specimens collected from each patient were tested for a panel of respiratory viruses
and bacteria using the Fast Track Diagnostic 21 Plus kit.
Results: We enrolled and tested 638 children aged younger than 5 years, of whom
411 (64.4%) were aged younger than 1 year, and 15 (2.4%) died during the study
period. Overall, 496/638 (77.7%) specimens tested positive for at least one respira-
tory virus or bacterium; of these, 195 (39.3%) tested positive for respiratory viruses,
126 (25.4%) tested positive for respiratory bacteria, and 175 (35.3%) tested positive
for both respiratory viruses and bacteria. The predominant viruses detected were
respiratory syncytial virus (RSV) (149/638; 23.3%), human parainfluenza virus (HPIV)
types 1 to 4 (78/638; 12.2%), human rhinovirus (HRV) (62/638; 9.4%), human adeno-
virus (HAV) (60/638; 9.4%), and influenza virus (INF) (52/638; 8.1%). Streptococcus
pneumoniae (249/638; 39.0%) was the most frequently detected bacterium, followed
by Staphylococcus aureus (112/638; 12.2%) and Haemophilus influenzae type B
(16/638; 2.5%). Chest X-rays were performed at the discretion of the attending phy-
sician on 301 (47.2%) case patients. Of these patients, 231 (76.7%) had abnormal
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radiological findings. A total of 135/638 (21.2%) and 572/638 (89.7%) children
received antibiotic treatment prior to admission and during admission, respectively.
Conclusion: A high proportion of respiratory viruses was detected among children
aged younger than 5 years with febrile ARI, raising concerns about excessive use of
antibiotics in Niger.
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1 | INTRODUCTION
Acute respiratory infections (ARIs) are responsible for elevated
childhood morbidity and mortality globally,1,2 accounting for approxi-
mately four million deaths among children aged younger than 5
years in 2010 and resulting in substantial burden of healthcare sys-
tems.3,4 In developing countries, ARIs account for 19% of all deaths
among children aged younger than 5 years and 8.2% of all disabil-
ities and premature deaths.5,6 Therefore, data on the epidemiology
and seasonality of ARI are important to develop control and preven-
tion strategies.7
In Niger, the estimated mortality rate among children aged
younger than 5 years was 114 per 1000 in 2012 (UNICEF child
mortality estimate), and more than 80% of these deaths were
associated with malaria, respiratory infections, and diarrhea.
According to the 2012 Niger health statistics yearbook, the esti-
mated case fatality proportion associated with respiratory infections
was 8.7%.
In the absence of laboratory diagnosis, it is difficult to clinically dif-
ferentiate between ARI-related causative pathogens, due to similari-
ties of symptoms.8,9 The main causative agents of ARI are viruses and
bacteria.10 Major viruses include respiratory syncytial virus (RSV),
human rhinovirus (HRV), influenza virus (INF) types A and B, human
adenovirus (HAV), human parainfluenza virus (HPIV), human meta-
pneumovirus (HMPV), and human coronavirus (HCOV), while major
bacterial pathogens include Streptococcus pneumoniae, Staphylococcus
aureus, and Haemophilus influenzae.11-13
In Niger, there is scarcity of data on ARIs, although a routine influ-
enza surveillance system exists. INF has been detected in 11% of sam-
ples from children aged younger than 5 years hospitalized with severe
acute respiratory illness (SARI).14 Knowledge on the etiology of ARI in
Niger could inform the selection of other important pathogens to be
included in routine surveillance and improve the clinical management
of patients.
This study aims to describe the viral and bacterial infections
among children aged younger than 5 years hospitalized with febrile
ARI at two national hospitals of Niamey, the capital city of Niger, and
the reported clinical procedures.
2 | METHODS
2.1 | Study design and setting
We conducted a prospective study among children aged younger than
5 years hospitalized with febrile ARI between January and December
2015. Niger has four distinct seasons as categorized by the national
directorate of meteorology: the cold season (mid-December to mid-
February), the dry season (mid-February to May), the rainy season
(June to September), and the hot season (October to mid-
December).15
This study was part of the “TOTAL Niger Infection Respiratoire
Aiguë” (TONIRA) Project, which was funded by the TOTAL Corporate
Foundation in order to strengthen medical care of febrile ARI among
children aged younger than 5 years. The study was conducted at the
pediatric wards of two national tertiary hospitals situated in Niamey,
namely, the Hôpital National de Niamey (HNN) and the Hôpital
National Lamordé (HNL). These two hospitals provide general health
care to the population of Niamey estimated at 1.1 million in 2015, as
well as to patients referred from across the country. Laboratory detec-
tion of respiratory viruses and bacteria were conducted at the Centre
de Recherche Médicale et Sanitaire (CERMES), Niamey, Niger (the
National Reference Laboratory for influenza).
Demographic and clinical data, as well as the use of antibiotics
before and during admission, were collected using standard data col-
lection forms. Malaria testing was implemented on site using thick
blood film microscopy. Chest X-rays were performed at the discretion
of the attending physician, and typical abnormal radiological findings
assessed included pulmonary opacities, acute bronchiolitis, and
enlargement of intercostal spaces. Malnutrition was determined using
the ratio of weight for height, and its level was classified as moderate
or severe by the attending physician using national standards based
on the 2010 Technical Guidelines for Integrated Disease Surveillance
and Response in the African Region (Retrieved from https://www.
afro.who.int/sites/default/files/2017-06/IDSR-Technical-Guidelines_
Final_2010_0.pdf). Febrile ARI in conjunction with malaria, malnutri-
tion, and diarrhea were assessed during admission using a standard-
ized case investigation form. In-hospital outcome (ie., discharge,
referral, or death) was recorded for all enrolled patients.
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2.2 | Case definition
A febrile ARI case was defined as a hospitalized child aged younger
than 5 years with onset of fever 38C or higher and cough within
10 days prior to admission and at least one of the following signs:
inability to drink or breastfeed, lethargy, vomiting, convulsions, nasal
flaring, chest indrawing, stridor in a calm child, or tachypnea.
2.3 | Sampling and laboratory testing
Nasopharyngeal swabs were collected from all enrolled patients,
placed in universal transport medium, stored at 4 to 8C, and trans-
ported to CERMES within 72 hours of collection, for testing. Respi-
ratory samples were tested for INF types A and B; HPIV types 1
to 4; HCoV NL63, 229E, OC43, and HKU1; HMPV A and B; RSV
A and B; human parechovirus (HPV); human enterovirus (HEV);
HAV; human bocavirus (HBoV); HRV; S pneumoniae; H influenzae
type B (Hib); S aureus; Mycoplasma pneumoniae; and Chlamydia
pneumoniae using the RT-qPCR Fast Track Diagnostic Respiratory
pathogens 21 Plus kit from Bio-Mérieux (catalog no. FTD 2
+-96/12), following the manufacturer's instructions. An internal con-
trol provided as part of the kit was used to monitor the sample
extraction and reverse transcription. RT-qPCR was performed using
the FTD Respiratory pathogens 21 plus kit as follows: the reaction
volume for each test was 25 μL, consisting of 10 μL of nucleic acid
and 15 μL of buffer/enzyme mix from the AgPath-ID One-Step RT-
PCR kit (Ambion, Life Technologies, USA, Catalog number
4387424). Amplification was performed using ABI 7500 Fast real-
time PCR system thermocycler (Applied Biosystems, USA,) and the
following cycling conditions were used: 50C at 15 minutes for
reverse transcription, 95C at 10 minutes for enzyme activation,
and 40 cycles of 95C at 8 seconds and 60C at 34 seconds for
TABLE 1 Detection of respiratory viruses and bacteria among children aged <5 years hospitalized with febrile acute respiratory infection in
Niamey, Niger, 2015
Characteristics Population N (%)
Detection n (%)
Any virus or bacterium Viruses only Bacteria only Viruses and bacteria
Total 638 496 (77.7) 195 (30.6) 126 (19.7) 175 (27.4)
Age (in y)
<1 411 (64.4) 327 (79.6) 141 (34.3) 70 (17.0) 116 (28.2)
1-4 227 (35.6) 169 (74.4) 54 (23.8) 56 (24.7) 59 (26.0)
Sex
Female 291 (45.6) 231 (79.4) 86 (29.5) 61 (21.0) 84 (28.9)
Male 347 (54.4) 265 (76.4) 109 (31.4) 65 (18.7) 91 (26.2)
Season of the yeara
Cold 108 (84.3) 64 (59.3) 27 (25.0) 25 (23.1) 12 (11.1)
Dry 213 (33.4) 175 (82.2) 80 (37.6) 28 (13.1) 67 (31.5)
Rainy 191 (29.9) 160 (83.8) 40 (20.9) 57 (29.8) 63 (33.0)
Hot 126 (19.8) 97 (77.0) 48 (38.1) 16 (12.7) 33 (26.2)
Malaria
No 538 (84.3) 415 (77.1) 159 (29.6) 110 (20.4) 146 (27.1)
Yes 100 (15.7) 81 (81.0) 36 (36.0) 16 (16.0) 29 (29.0)
Diarrhea
No 524 (82.1) 407 (77.7) 164 (31.3) 100 (19.1) 143 (27.3)
Yes 114 (17.9) 89 (78.1) 31 (27.2) 26 (22.8) 32 (28.1)
Malnutrition
No 524 (82.1) 406 (77.5) 154 (29.4) 102 (19.5) 150 (28.6)
Moderate 40 (6.3) 34 (85.0) 17 (42.5) 5 (12.5) 12 (30.0)
Severe 74 (11.6) 56 (75.7) 24 (32.4) 19 (25.7) 13 (17.6)
Antibiotics on admission
No 66 (10.3) 50 (75.8) 20 (30.3) 9 (13.6) 21 (31.8)
Yes 572 (89.7) 446 (78.0) 175 (30.6) 117 (20.4) 154 (26.9)
Death
No 623 (97.6) 482 (77.4) 188 (30.2) 122 (19.6) 172 (27.6)
Yes 15 (2.4) 14 (93.3) 7 (46.7) 4 (26.7) 3 (20.0)
aWhen the patient was hospitalized.
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amplification. The fluorescence was assessed at the amplification
step. The positive and negative virus plasmid controls provided in
the kit were included in all runs to monitor assay performance.16
2.4 | Statistical analysis
Viral and/or bacterial detection was reported as percentage positive,
overall and within selected categories (eg, age groups and seasons).
Children aged younger than 5 years were stratified into two age
groups: infants (aged younger than 1 year) and young children (aged
1-4 years), for comparability with other studies from Africa.17-20 In
addition, the majority of enrolled children were aged younger than
1 year hindering our ability to categorize age in smaller age groups.
Stata version 14.2 (StataCorp, College Station, Texas, USA) was used
for the analysis.
2.5 | Ethical approval
The protocol was approved by the National Ethical Consultative Com-
mittee (CCNE) of Niger and by the Clinical Research Committee
(CoRC) of the Institut Pasteur, Paris. Proxy informed consent was
obtained from parents or legal guardians of children. All children who
did not meet the case definition or for whom verbal consent was not
obtained were not included in the study.
3 | RESULTS
3.1 | Study population
Between January and December 2015, we enrolled and tested
638 children aged younger than 5 years. Of these, 411 (64.4%) were
aged younger than 1 year, 347 (54.4%) were male, and 365 (57.3%)
were admitted at the HNN. Of the comorbidities investigated, malaria,
malnutrition, and diarrhea were diagnosed in 100 (15.7%),
114 (17.9%), and 114 (17.9%) case patients, respectively. Of the
114 malnourished children identified, 74 (64.9%) had severe malnutri-
tion (Table 1). Chest X-rays were performed on 301 (47.2%) case
patients. Of these patients, 231 (76.7%) had abnormal radiological
findings, of which the most common were pulmonary opacity (106;
45.9%), extension of the intercostal space (99; 42.8%), and bronchioli-
tis (21; 9.1%). One hundred thirty-five (21.2%) children received anti-
biotic treatment within 3 days prior to admission, and 572 (89.7%)
children were prescribed antibiotic treatment during admission. The
in-hospital case fatality proportion was 2.4% (15/638) overall; 2.9%
(12/411) and 1.3% (3/227) among children aged younger than 1 and
1 to 4 years, respectively.
3.2 | Detection of viral and bacterial agents
Overall, 496/638 (77.7%) specimens tested positive for at least one
respiratory virus or bacterium (Table 1). Of the 496 positive speci-
mens, 195 (39.3%) tested positive for respiratory viruses only,
126 (25.4%) tested positive for respiratory bacteria only, and
175 (35.3%) tested positive for both respiratory viruses and bacteria.
Single virus or bacterium was detected in 229/496 (46.2%) positive
specimens, of which 140 (61.1%) were single viral infections
(Figure 1). The number of viral and/or bacterial detection among posi-
tive specimens ranged between 1 and 5.
Antibiotics were prescribed to 89.7% (175/195), 92.8% (117/126),
and 88.0% (154/175) of patients with viral only, bacterial only, or viral
and bacterial detection, respectively.
3.3 | Individual detection of respiratory viruses
Overall, respiratory viruses were detected in 370/638 (58.0%) speci-
mens. RSV (149/638; 23.3%), HPIV types 1 to 4 (78/638; 12.2%),
HRV (62/638; 9.4%), HAV (60/638; 9.4%), and INF (52/638; 8.1%)
were the predominant viruses detected (Table 2). Of the HPIV-
F IGURE 1 Detection (including
codetection) of respiratory viruses and
bacteria among children aged <5 years
hospitalized with febrile acute respiratory
infection in Niamey, Niger, 2015 (the size
of the circles is proportional to the
number of specimens within each
category; percentages are expressed over
total number of positive specimens: 496)
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positive specimens, HPIV-3 was the most commonly detected one
(48/78; 61.5%), whereas INF type A predominated among the
influenza-positive specimens (46/52; 88.5%). HCoVs were detected in
8.0% (51/638) of specimens, and OC43 was the mostly detected one
(44/51; 86.3%). HMPV, HBoV, and HEV were detected individually in
less than 5% of specimens. HPV was the least commonly detected
respiratory virus (1/638; 0.2%).
Of the specimens that tested positive for at least one respiratory
virus, two or more respiratory viruses were detected in 104/370
(28.1%) specimens, of which dual detection occurred in 72/104
(69.2%) specimens. RSV (95/149; 63.8%), HMPV (17/28; 60.7%), and
INF (31/52; 59.6%) were mostly detected in specimens with single
viral infection, whereas HPV (1/1; 100.0%), HEV (6/8; 75.0%), HAV
(38/60; 63.3%), HBoV (13/22; 59.1%), and HRV (34/62; 54.8%) were
mostly detected in specimens with two or more viral infections
(Figure 2A). The number of viral detections among virus-positive spec-
imens ranged between 1 and 4. Among patients with abnormal radio-
logical findings, respiratory viruses were most commonly detected
among patients with bronchiolitis (19/21; 90.5%). RSV and HPIV were
mostly detected among children aged younger than 1 compared with
1 to 4 years (Table 2).
Regarding seasonality, INF was mostly detected during the cold
season, HPIV and HCoV were mostly detected during the dry season,
HRV was mostly detected during the rainy season, and RSV and
HMPV were mostly detected during the hot season (Table 2 and
Figure 3A).
3.4 | Individual detection of respiratory bacteria
Overall, respiratory bacteria were detected in 301/638 (47.2%) speci-
mens. S pneumoniae (249/638; 39.0%) was the most frequently
detected bacterium, followed by S aureus (112/638; 12.2%) and Hib
(16/638; 2.5%) (Table 3). M pneumoniae and C pneumoniae were
detected individually in less than 1% of specimens.
Of the specimens that tested positive for at least one respiratory
bacteria, two or more respiratory bacteria were detected in 81/220
(26.9%) specimens, of which dual detection occurred in 80/81 (98.8%)
of specimens. S pneumoniae (170/249; 68.3%) was mostly detected in
specimens with a single bacterial infection, whereas Hib (13/16;
54.8%) and S aureus (68/112; 60.7%) were mostly detected in
specimens with two or more bacterial infections (Figure 2B). The num-
ber of bacterial detections among bacteria-positive specimens ranged
between 1 and 3. Among patients with abnormal radiological findings,
respiratory bacteria were most commonly detected among patients
with pulmonary opacity (87/106; 90.5%).
S pneumoniae and S aureus were mostly detected during the rainy
season (June to September) (Table 3 and Figure 3B).
4 | DISCUSSION
We report the detection of respiratory viruses and bacteria among
children aged younger than 5 years hospitalized with febrile ARI inT
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Niger between January and December 2015. At least one respiratory
virus or bacteria was found in 77.7% of samples tested. This propor-
tion was similar to that reported in a previous study on the etiology of
ARI in children aged younger than 5 years in Niger (78%), although on
a limited number of samples.8 This finding was also consistent with
those of other similar studies conducted in Africa (range 55%-
70%)21,22 and Asia (range 45%-65%).23-25
The positivity proportion of respiratory viruses varied consider-
ably. RSV, HPIV, HRV, HAV, and INF were the most commonly
detected viruses. As reported in other studies, RSV, INF, and HMPV
were mostly detected as single viral infections.26,27 RSV, HRV, and
HPIV were also the most predominant viruses detected in children
aged younger than 5 years in a previous study conducted in Niger.8
RSV is considered to be a major cause of ARI in children aged younger
than 5 years,26,28-30 and it was the most commonly detected virus also
in this study (149/638; 23.3%).
Among the cases in which HPIV and HCoV were detected, HPIV
type 3 and HCoV type OC43 were the predominant types, and this is
consistent with previous studies.27,31 In this study, INFs were
detected in 8.5% of the cases, which is in agreement with findings
from the national influenza surveillance14 and other related studies in
Africa among patients hospitalized with SARI.18,32,33 A higher
influenza positivity proportion has been reported among outpatients
with influenza-like illness.13,28
F IGURE 2 Proportion of single and multiple (A) viral and (B) bacterial detections among children aged <5 years hospitalized with febrile acute
respiratory infection in Niamey, Niger, 2015. HAV, human adenovirus; HBoV, human bocavirus; HCoV, human coronavirus; HEV, human
enterovirus; HPIV, human parainfluenza virus; HPV, human parechovirus; HRV, human rhinovirus; INF, influenza virus; RSV, respiratory syncytial
virus
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During the 1-year study period, respiratory viruses were detected
throughout the four seasons.15 However, RSV was mostly detected
during the hot and dry seasons with higher temperature and lower rel-
ative humidity,7 whereas INFs were mostly detected during the cold
and rainy seasons, as reported from influenza sentinel surveillance in
Niger.14,34 If these seasonal patterns are confirmed in multiyear stud-
ies, they could be useful for epidemic preparedness and response
plans.
High colonization rates of S pneumoniae, S aureus, and Hib have
been reported in children, but only a fraction of colonization events
have been reported to result in disease.35,36 S pneumoniae was
detected in 39.5% of specimens, and it was the bacteria predomi-
nantly detected in our samples. However, the colonization rate found
in this study was lower than that reported in a study conducted in
2014 (54.5%), which could be attributed to the introduction of the
13-valent pneumococcal conjugate vaccination (PCV13) in Niger that
same year.37 The very low detection rate of Hib (2.5%) may also be
attributed to the introduction of the Hib conjugate (tetanus toxoid)
vaccine in the expanded immunization program in 2008 in Niger.38
Uncommon respiratory bacterial pathogens including M pneumoniae
and C pneumoniae were detected at a very low rate (less than 1%), and
this correlates with the results reported in previous studies.10,26,27
F IGURE 3 Weekly number of specimens positive for respiratory (A) viruses and (B) bacteria in Niamey, Niger, 2015
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TABLE 3 Detection of individual respiratory bacteria among children aged <5 years hospitalized with febrile acute respiratory infection in
Niamey, Niger, 2015
Characteristics
Detection n (%)
Streptococcus
pneumoniae
Staphylococcus
aureus
Haemophilus influenzae
type B
Mycoplasma
pneumoniae
Chlamydia
pneumoniae
Any
bacterium
Total (N = 638) 249 (39.0) 112 (17.5) 16 (2.5) 4 (0.6) 2 (0.3) 301 (47.2)
Age (in y)
<1 (N = 411) 152 (37.0) 68 (16.5) 8 (1.9) 3 (0.7) 1 (0.2) 186 (45.3)
1-4 (N = 227) 97 (42.7) 44 (19.4) 8 (3.5) 1 (0.4) 1 (0.4) 115 (50.7)
Sex
Female (N = 291) 121 (41.6) 51 (17.5) 10 (3.4) 2 (0.7) 1 (0.3) 145 (49.8)
Male (N = 347) 128 (36.9) 61 (17.6) 6 (1.7) 2 (0.6) 1 (0.3) 156 (45.0)
Season of the yeara
Cold (N = 108) 31 (28.7) 11 (10.2) 3 (2.8) 0 (0.0) 0 (0.0) 37 (34.3)
Dry (N = 213) 69 (32.4) 43 (20.2) 3 (1.4) 1 (0.5) 2 (0.9) 95 (44.6)
Rainy (N = 191) 105 (55.0) 47 (24.6) 7 (3.7) 2 (1.0) 0 (0.0) 120 (62.8)
Hot (N = 126) 44 (34.9) 11 (8.7) 3 (2.4) 2 (0.8) 0 (0.0) 49 (38.9)
Malaria
No (N = 538) 210 (39.0) 93 (17.3) 14 (2.6) 2 (0.4) 2 (0.4) 256 (47.6)
Yes (N = 100) 39 (39.0) 19 (19.0) 2 (2.0) 2 (2.0) 0 (0.0) 45 (45.0)
Diarrhea
No (N = 524) 196 (37.4) 95 (18.1) 12 (2.3) 3 (0.6) 2 (0.4) 243 (46.4)
Yes (N = 114) 53 (46.5) 17 (14.9) 4 (3.5) 1 (0.9) 0 (0.0) 58 (50.9)
Malnutrition
No (N = 524) 208 (39.7) 95 (18.1) 14 (2.7) 4 (0.8) 2 (0.4) 252 (48.1)
Moderate (N = 40) 14 (35.0) 6 (15.0) 0 (0.0) 0 (0.0) 0 (0.0) 17 (42.5)
Severe (N = 74) 27 (36.5) 11 (14.9( 2 (2.7) 0 (0.0) 0 (0.0) 32 (43.2)
Antibiotics on admission
No (N = 66) 21 (31.8) 15 (22.7) 0 (0.0) 0 (0.0) 1 (1.5) 30 (45.4)
Yes (N = 572) 228 (39.9) 97 (17.0) 16 (2.8) 4 (0.7) 1 (0.2) 271 (47.4)
Death
No (N = 623) 243 (39.0) 111 (17.8) 16 (2.6) 3 (0.5) 2 (0.3) 294 (47.2)
Yes (N = 15) 6 (40.0) 1 (6.7) 0 (0.0) 1 (6.7) 0 (0.0) 7 (46.7)
Viruses
Any (N = 370) 142 (38.4) 65 (17.6) 8 (2.2) 2 (0.5) 2 (0.3) 175 (47.3)
RSV (N = 149) 50 (33.6) 26 (17.4) 2 (1.3) 0 (0.0) 1 (0.7) 67 (45.0)
HPIV (N = 78) 28 (35.9) 10 (12.8) 3 (3.8) 0 (0.0) 0 (0.0) 32 (41.0)
HRV (N = 62) 24 (38.7) 11 (17.7) 2 (3.2) 1 (1.6) 0 (0.0) 30 (48.4)
HAV (N = 60) 28 (46.7) 9 (15.0) 2 (3.3) 1 (1.7) 0 (0.0) 31 (51.7)
INF (N = 52) 20 (38.5) 8 (15.4) 4 (7.7) 1 (1.9) 0 (0.0) 25 (48.1)
HCoV (N = 51) 18 (35.3) 8 (15.7) 0 (0.0) 0 (0.0) 1 (2.0) 23 (45.1)
HMPV (N = 28) 11 (39.0) 5 (17.9) 0 (0.0) 0 (0.0) 0 (0.0) 12 (42.9)
HBoV (N = 22) 10 (45.4) 7 (31.8) 0 (0.0) 0 (0.0) 0 (0.0) 13 (59.1)
HPV (N=1) 1 (100.0) 1 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (100.0)
Abbreviations: HAV, human andenovirus; HBoV, human bocavirus; HCoV, human coronavirus; HEV, human enterovirus; HMPV, human metapneumovirus;
HPV, human parechovirus. HPVI, human parainfluenza virus; HRV, human rhinovirus; INF, influenza virus; RSV, respiratory syncytial virus.
aWhen the patient was hospitalized.
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In our study, 21.2% of children had already received antibiotics
before hospitalization, and nearly all children (89.7%) received antibi-
otics during admission. These findings are consistent with a study
from Mali, which reported a rate of antibiotics uptake of 39.8% before
admission and elevated antibiotics usage (more than 95%) on admis-
sion.39 The national guidelines for ARI treatment based on the Inte-
grated Management of Childhood Illness (Manuel sur la Prise en
Charge Integrée des Maladies de l'Enfant (PCIME) (2001), retrieved
from https://apps.who.int/iris/bitstream/handle/10665/67167/
WHO_FCH_CAH_00.12_fre.pdf;jsessionid=
65C124F019A55837AF0B229E9AB1B21A?sequence=1) include the
systematic use of antibiotics for empiric treatment to prevent superin-
fection. However, considering the high number of patients from whom
only respiratory viruses were detected, this practice raises concern
about the potentially excessive use of antibiotics—and resistance
development—in Niger.28
About 15% to 17% of patients with febrile ARI also had diarrhea,
were malnourished, or were coinfected with malaria. This could be
explained by the fact that these infections constitute some of the
leading public health concerns in Niger and are responsible for ele-
vated childhood mortality (Annuaire des statistiques sanitaires du
Niger) (2016). Retrieved from http://www.stat-niger.org/statistique/
file/Annuaires_Statistiques/snis/Annuaire_statistiques_2016.pdf).
Our study presents some limitations. First, the study spanned over
a period of only 12 months, limiting our ability to fully assess the tem-
poral circulation pattern of the investigated agents. Due to the small
sample size, we may also have been underpowered to detect small
variations in the temporal distribution of the investigated agents. Sec-
ond, attribution of causality remains challenging due to the lack of
controls in our study. The association of pathogen detection with ill-
ness could not be well assessed, although most of the viral and bacte-
rial pathogens identified in this study have been described in previous
case control studies as causative agents of ARI.10,39 In addition, we
did not collect blood samples to assess whether the detection of com-
mon bacterial colonizers of the nasopharynx, such as S pneumoniae,
were associated with invasive disease. Third, we did not record the
number of patients with febrile ARI that refused enrollment, hindering
our ability to estimate underenrollment. Last, given that only patients
with febrile ARI were enrolled, this could have resulted in an underes-
timation of the RSV burden since a large proportion of RSV-related ill-
ness is not associated with fever.40
5 | CONCLUSIONS
In this 1-year prospective study, both viral and bacterial pathogens
were detected in high proportion among hospitalized children aged
younger than 5 years with febrile ARI in Niamey, Niger. However,
further investigations should be carried out to assess risk factors
and association of pathogens with illness. Although national guide-
lines for ARI treatment recommend systematic empiric antibiotic
therapy, our results suggest that antibiotic use might be unneces-
sary in most cases, given the predominance of viral infections as
potential cause of febrile ARI. Furthermore, other predisposing dis-
eases such as malaria, malnutrition, and diarrhea may be contribu-
tory factors to febrile ARI exacerbation among hospitalized
children.
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